skip to main content
UTRGV The University of Texas Rio Grande Valley
Main Menu
Donate Now Listado myUTRGV

You are here:

Inicio Noticias Dr. Mario Gil awarded NIH K01 Grant
English

Centro de Recursos sobre la Enfermedad de Alzheimer para la Investigación del Envejecimiento de las Minorías Facultad de Medicina de UTRGV

  • Inicio
  • Núcleos de Investigación
    • Núcleo Administrativo
      • Informes de Actividades AD-RCMAR
    • Núcleo Analítico
    • Núcleo de Enlace y Captación Comunitarios
    • Componente de Educación Investigativa
      • Programa de Estudios Piloto
  • Científicos de RCMAR
  • Estudios Piloto en Curso
  • Programa de Afiliación a AD-RCMAR
  • Recursos
    • Seminarios de Investigación en Neurociencias
      • Alzhéimer y Demencias Afines
      • Equidad Cerebral
      • Determinantes Sociales de la Salud
      • Oradores Anteriores
  • Publicaciones

Contacto

Dra. Gladys E. Maestre
Directora
Correo electrónico: Gladys.Maestre@utrgv.edu
Teléfono: (956) 882-7594
Fax: (956) 665-9797

Enlaces principales

  • ¿Qué es la enfermedad de Alzheimer?
  • Información adicional sobre RCMAR y otros recursos de investigación
  • Oportunidades de financiación
  • Noticias
  • Actividades

Dr. Mario Gil awarded NIH K01 Grant

Dr. Mario Gil awarded an NIH K01 grant to study heart regulating systems that underlie neural regulation of psychosocial stress responses

Dr. Mario Gil, assistant professor at the UTRGV Department of Psychological Sciences and one of our RGV AD-RCMAR Scientist was awarded a K01 grant to test the hypothesis that Avpr1a V1AR gene expression patterns predict arginine-vasopressin effects on psychosocial-stress in an animal myocardial ischemia-reperfusion injury model.

The purpose of the NIH K01 program is to provide support and protected time for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Some NIH Institutes use the K01 to enhance workforce diversity, or for individuals who propose to train in a new field, or for individuals who have had a hiatus in their research careers.

This K01 grant stems from Dr. Gil’s pilot research at the RGV AD-RCMAR, where he focused on the neurobiology of social behavior and social stressors in older Hispanics. The proposed study will explore the therapeutic potential of arginine-vasopressin, acting via the V1A receptor, in treating stress-associated cardiovascular conditions.

We congratulate Dr. Gil for this award, and we hope this project will open more research opportunities for him and strengthen his career in minority aging research.

Gladys E. Maestre, MD, PhD.
Director, RGV AD-RCMAR


Jump to Top

UTRGV

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • CARES, CRRSAA and ARP Reporting
  • Site Policies
  • Contact UTRGV
  • Required Links
  • Fraud Reporting
  • Senate Bill 18 Reporting
  • UTRGV Careers
  • Clery Act Reports
  • Web Accessibility
  • Mental Health Resources
  • Sexual Misconduct Policy
  • Reporting Sexual Misconduct